Cargando…
Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory
BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) remains largely underdiagnosed despite recommendations of healthcare institutions and programmes designed to increase awareness. The objective was to analyse the trends in AATD diagnosis during the last 5 years in a Spanish AATD reference laboratory....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548232/ https://www.ncbi.nlm.nih.gov/pubmed/33116457 http://dx.doi.org/10.2147/COPD.S269641 |
_version_ | 1783592581143199744 |
---|---|
author | Belmonte, Irene Nuñez, Alexa Barrecheguren, Miriam Esquinas, Cristina Pons, Mònica López-Martínez, Rosa M Ruiz, Gerard Blanco-Grau, Albert Ferrer, Roser Genescà, Joan Miravitlles, Marc Rodríguez-Frías, Francisco |
author_facet | Belmonte, Irene Nuñez, Alexa Barrecheguren, Miriam Esquinas, Cristina Pons, Mònica López-Martínez, Rosa M Ruiz, Gerard Blanco-Grau, Albert Ferrer, Roser Genescà, Joan Miravitlles, Marc Rodríguez-Frías, Francisco |
author_sort | Belmonte, Irene |
collection | PubMed |
description | BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) remains largely underdiagnosed despite recommendations of healthcare institutions and programmes designed to increase awareness. The objective was to analyse the trends in AATD diagnosis during the last 5 years in a Spanish AATD reference laboratory. METHODS: This was a retrospective revision of all alpha-1 antitrypsin (AAT) determinations undertaken in our laboratory from 2015 to 2019. We analysed the number of AAT determinations performed and described the characteristics of the individuals tested, as well as the medical specialties and the reasons for requesting AAT determination. RESULTS: A total of 3507 determinations were performed, of which 5.5% corresponded to children. A significant increase in the number of AAT determinations was observed from 349 in 2015 to 872 in 2019. Among the samples, 57.6% carried an intermediate AATD (50–119 mg/dL) and 2.4% severe deficiency (<50 mg/dL). The most frequent phenotype in severe AATD individuals was PI*ZZ (78.5%), and aminotransferase levels were above normal in around 43% of children and 30% of adults. Respiratory specialists requested the highest number of AAT determinations (31.5%) followed by digestive diseases and internal medicine (27.5%) and primary care physicians (19.7%). The main reason for AAT determination in severe AATD adults was chronic obstructive pulmonary disease (41.7%), but reasons for requesting AAT determination were not reported in up to 41.7% of adults and 58.3% of children. CONCLUSION: There is an increase in the frequency of AATD testing despite the rate of AAT determination remaining low. Awareness about AAT is probably increasing, but the reason for testing is not always clear. |
format | Online Article Text |
id | pubmed-7548232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75482322020-10-27 Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory Belmonte, Irene Nuñez, Alexa Barrecheguren, Miriam Esquinas, Cristina Pons, Mònica López-Martínez, Rosa M Ruiz, Gerard Blanco-Grau, Albert Ferrer, Roser Genescà, Joan Miravitlles, Marc Rodríguez-Frías, Francisco Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) remains largely underdiagnosed despite recommendations of healthcare institutions and programmes designed to increase awareness. The objective was to analyse the trends in AATD diagnosis during the last 5 years in a Spanish AATD reference laboratory. METHODS: This was a retrospective revision of all alpha-1 antitrypsin (AAT) determinations undertaken in our laboratory from 2015 to 2019. We analysed the number of AAT determinations performed and described the characteristics of the individuals tested, as well as the medical specialties and the reasons for requesting AAT determination. RESULTS: A total of 3507 determinations were performed, of which 5.5% corresponded to children. A significant increase in the number of AAT determinations was observed from 349 in 2015 to 872 in 2019. Among the samples, 57.6% carried an intermediate AATD (50–119 mg/dL) and 2.4% severe deficiency (<50 mg/dL). The most frequent phenotype in severe AATD individuals was PI*ZZ (78.5%), and aminotransferase levels were above normal in around 43% of children and 30% of adults. Respiratory specialists requested the highest number of AAT determinations (31.5%) followed by digestive diseases and internal medicine (27.5%) and primary care physicians (19.7%). The main reason for AAT determination in severe AATD adults was chronic obstructive pulmonary disease (41.7%), but reasons for requesting AAT determination were not reported in up to 41.7% of adults and 58.3% of children. CONCLUSION: There is an increase in the frequency of AATD testing despite the rate of AAT determination remaining low. Awareness about AAT is probably increasing, but the reason for testing is not always clear. Dove 2020-10-07 /pmc/articles/PMC7548232/ /pubmed/33116457 http://dx.doi.org/10.2147/COPD.S269641 Text en © 2020 Belmonte et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Belmonte, Irene Nuñez, Alexa Barrecheguren, Miriam Esquinas, Cristina Pons, Mònica López-Martínez, Rosa M Ruiz, Gerard Blanco-Grau, Albert Ferrer, Roser Genescà, Joan Miravitlles, Marc Rodríguez-Frías, Francisco Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title_full | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title_fullStr | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title_full_unstemmed | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title_short | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
title_sort | trends in diagnosis of alpha-1 antitrypsin deficiency between 2015 and 2019 in a reference laboratory |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548232/ https://www.ncbi.nlm.nih.gov/pubmed/33116457 http://dx.doi.org/10.2147/COPD.S269641 |
work_keys_str_mv | AT belmonteirene trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT nunezalexa trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT barrechegurenmiriam trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT esquinascristina trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT ponsmonica trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT lopezmartinezrosam trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT ruizgerard trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT blancograualbert trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT ferrerroser trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT genescajoan trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT miravitllesmarc trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory AT rodriguezfriasfrancisco trendsindiagnosisofalpha1antitrypsindeficiencybetween2015and2019inareferencelaboratory |